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In vitro bioactivity
Stem cells attachmentThree dimensionally ordered macroporous bioactive SiO2 CaO Na2O P2O5 glass (3DOM BG) is synthesized by
using the sol gelmethod. After an in vitro test in simulated body ﬂuid (SBF), the hydroxyapatite (HAp) crystalline
phase is clearly formed on its surface as conﬁrmed byX ray diffractometry (XRD) and Raman spectroscopy. Mag
netic 3DOM BG/Fe samples are synthesized bypartial substitution of SiO2with iron oxide.Whilst theHAp layer is
not conﬁrmed, energy dispersive spectroscopy (EDS), Fourier transform infrared spectroscopy (FTIR) and XRD
analysis reveal calciumphosphate layer on the surface of 3DOM BG/Fe samples after the SBF soaking. The growth
ofHAp like layer is slowerwith increasing iron oxides. The initial mechanism that thought to induce bone forma
tion is reduced due to the replacement of Ca2+with Fe ions in the glass network. The formation of HAp like layer
is modiﬁed by the sedimentation of Ca and P while the nonmagnetic 3DOM BG forms the calcium phosphate by
the ionic exchange following theHenchmechanism. The adult human adipose tissue derived stem cells (hADSCs)
can be closely attached and well spread on the ﬂat plate of all 3DOM BG/Fe and 3DOM BG. Without detectable
cytotoxicity possibly induced by iron oxides, the osteoblast can be grown and proliferated. In addition to these
bioactivity and biocompatibility, porous structures can allow their possible use in targeted drug delivery and
magnetic properties of 3DOM BG/Fe can essentially be implemented in hyperthermia therapy.1. Introduction
The bioactivity of bioactive glasses has been proven by either in vivo
test in physiological environment or in vitro test in simulated body ﬂuid
(SBF). The in vitro test in SBF is internationally accepted valid method to
verify the bone bonding ability with the formation of hydroxyl carbonate
apatite (HCA) as the bone like layer [1 3]. The reﬁned recipe of conven
tional SBFwas proposed to the Technical Committee ISO/TC150 of Interna
tional Organization for Standardization in 2003 by Kokubo [1]. Similar
compositions and ionic concentrations in human blood plasma and the
SBF were also presented [1]. The bone bonding ability of bioactive glasses
is determined from the biodegradability, the dissolution rate of its ions, the
formation of newbone tissues and the stimulation of osteoblastswhen ex
posed to physiological ﬂuids or SBF. Particularly, the temperature of the in
vitro testing for HCA formation of bioactive glasses in SBFmust be compa
rable to the body temperature of 37 °C. The mechanisms of bone bonding
reported, especially the ﬁrst 5 reaction stages generally referred to as the
Hench mechanism, suggestively conﬁrm the glass bioactivity [2 6].itkul).
laam, Tanzania.Initially, the network modiﬁcations of Na+ and Ca2+ ions at the in
terface of glasses are dissolved and replaced by H+ from the physiolog
ical ﬂuid according to ion exchange reactions in Eqs. (1) and (2).
Si−O−Naþ þ H2O → Si−OHþ þ Naþ þ OH ð1Þ
Si−O−Ca2þ þ H2O → Si−OHþ þ Ca2þ þ OH ð2Þ
The increase in pH with increasing OH− promotes the breaking of
siloxane groups (Si O Si). Si(OH)4 is partly released and silanol groups
(Si OH) are developed at the surface according to Eq. (3).
Si−O−Siþ H2O → Si−OHþ OH−Si ð3Þ
Owing to the depletion of Na+ and Ca2+ ions on the surface, the
silica rich layer then condenses and repolymerises on the glass surface
as follows.
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Table 1
Chemicals used in the synthesis of 3DOM-BG and 3DOM-BG/Fe.
Sample
codes
Composition SiO2-CaO-Na2O-P2O5-Fe
(mol%)
P123
(g)
TEOS
(mL)
TEP
(mL)
1 M NaNO3
(mL)
Ca(NO3)2·
4H2O (g)
Fe(NO3)3·9H2O
(g)
1 M HNO3
(mL)
EtOH
(mL)
80S/0Fe 80-10-5-5-0 0.667 1.79 0.15 1.00 0.236 – 1.00 2.50
70S/10Fe 70-10-5-5-10 0.581 1.57 0.15 1.00 0.236 0.404 1.00 2.50
60S/20Fe 60-10-5-5-20 0.506 1.34 0.15 1.00 0.236 0.808 1.00 2.50
50S/30Fe 50-10-5-5-30 0.417 1.12 0.15 1.00 0.236 1.212 1.00 2.50The Ca2+ and PO43− groups inside of glasses thenmigrate to the sur
face at silica rich layer. By incorporating Ca2+ and PO43− ions in the
body ﬂuid, the amorphous CaO P2O5 ﬁlm is formed. The ﬁlm growth re
sults in the presence of CaO P2O5 rich layer on the top surface. The
amorphous CaO P2O5 rich layer incorporates OH− and/or CO32− anions
from the surrounding solution. Finally, the HCA is biologically crystal
lized and new bone tissue is formed by interactions with other biomol
ecules and cells [2,3].
The continuous reactions after the ﬁrst 5 stages lead to the implant
site for bone tissue repair. The attachment of stem cells, the proliferation
and the differentiation of the cells successively occur on the surface of
bioactive glasses. The bone mineralization is ﬁnally developed with a
strong bond to the implant surface [3,7].Fig. 1. FESEM images of 80S/0Fe 3DOM-BG (a) before soaking in SBF and after soaking in SB
magniﬁcation.The in vitro osteogenesis is normally used to assess the potential of
the bioactive glasses in bone regeneration. Several human osteoblasts
like cells, i.e. MG 63 cells [8], ROS17/2.8 cells [9], bone marrow stromal
cells (BMSC) [10], HeLa cells [11], mesenchymal stromal cells (MSC)
[12] were studied for the cell adhesive on the surface of bioactive
glass samples. These cells were cultured in the mediums (MEM,
DMEM, etc.) and supplements (fetal bovine serum, penicillin, strepto
mycin, etc.) with the controlled temperature at 37 °C in an incubator
with simulated human body conditions [13 14]. The biocompatibility
in these studies are determined by the cell adhesion ability. The attach
ment and subsequent proliferation of the osteoblasts like cells have
been frequently reported. The morphology and spreading of cells de
pend on several factors such as the type of cells, the composition ofF for (b) 7 days, (c) 14 days, (d) 21 days, (e) 28 days and (f) 28 days shown in a lower
Fig. 2. FESEM images of sample 80S/0Fe showing (a) silica dissolution frommicrospheres after soaking in SBF for 7 days and (b)HAp crystalline growth on the surface ofmicrosphere after
soaking in SBF for 28 days.bioactive glass samples and the surfacemicro andmacro structure and
roughness. The bridging of cells over small pores has been observed. The
modiﬁcations of porous structures and scaffolds signiﬁcantly enhance
the attachment and proliferation of cell [10]. The interconnected porous
structure of the scaffolds supports the vascularization, nutrient as well
as allow their use for targeted drug delivery and the tissue growth. By
contrast, like any ceramic brittle material its porosity weakensmechan
ical properties. It has been reported that whereas the doping of MnO2
and Fe2O3 results in the decrease of bioactivity, the cell adhesion and
proliferation are facilitated [9]. Since, the hydroxyapatite (HAp) is sim
ilar to the major component of human bone, its formation on sample
surfaces are believed to enhance cell adhesion and signify the potential
for bone tissue regenerations [11,15].
In this study, two glass structures were produced to investigate their
bioactivity and biocompatibility. Major aim of the introduction of Fe
ions into the structure was their possible use in hyperthermia therapy
for cancer patients. The 3DOM structure were obtained in as widely ac
cepted bioactive glass (3DOM BG) and magnetic bioactive glass with
the addition of Fe into the structure (3DOM BG/Fe), Both glasses were
produced with hierarchical interconnected macropores similar to bone
tissues. The HAp formationwasmonitored to investigate the bioactivity
using the SBF in vitro test. The stem cells attachment after culturingwas
examined to verify the bioactivity and biocompatibility. The surfacial
changes of 3DOM BG and 3DOM BG/Fe were inspected and compared.Fig. 3. EDS analysis of elemental composition of 80The induction of osteoblast on their surfaces indicated that the ma
terials developed can be used to induce the new bone tissue formation.
The superparamagnetic properties were obtained by adding 10
30 mol% Fe(NO3)3 ⋅9H2O into SiO2 CaO Na2O P2O5 glasses which were
aimed to be used in hyperthermia therapy.
2. Experimental
2.1. Preparation of 3DOM BG and 3DOM BG/Fe
Based on T. Charoensuk et al. previously published procedure [16],
four samples were synthesized with varying compositions of chemicals
listed in Table 1. Sample 80S/0Fe was composed of 80SiO2 10CaO
5Na2O 5P2O5 and used as a nonmagnetic reference. Three 3DOM BG/
Fe samples referred to as 70S/10Fe, 60S/20Fe and 50S/30Fe were re
spectively prepared with Fe composition of 10, 20 and 30 mol%. Mag
netic iron oxide was reduced and incorporated under the reducing
carbon environment produced by the thermal decomposition of P123
during the calcination in air atmosphere [11].
2.2. In vitro SBF test
The bioactivity of the obtained samples were examined using r SBF
at pH 7.25 following Kokubo method [1]. The grainy 3DOM BG and
3DOM BG/Fe were soaked in SBF. The SBF was daily refreshed andS/0Fe sample before and after soaking in SBF.
Fig. 5. Raman spectra of sample 80S/0Fe before and after soaking in SBF for 28 days.
Fig. 4. FTIR spectra of sample 80S/0Fe before and after soaking in SBF.kept at 37 °C to simulate the in vivo situation. The soaking intervalswere
varied up to 28 days. After soaking, the samples were removed from the
SBF, washed 3 times with deionized water and then air dried at the
room temperature. The formation of HCA on their surfaces was moni
tored by ﬁeld emission scanning electron microscopy (FESEM), energy
dispersive spectroscopy (EDS), X ray diffractometry (XRD), Raman
and Fourier transform infrared (FTIR) spectroscopy.
2.3. Stem cells attachment
Adult human adipose tissue derived stem cells (hADSCs) tissue cul
ture was conducted under aseptic sterile conditions in a class II laminar
ﬂow hood (Clyde Apac BH2000 series). The hADSCs were cultured till
sub conﬂuence at 5 × 104 cells/cm2 T25 culture ﬂask (Nunc) in
Dulbecco's modiﬁed Eagle medium (D MEM: Glutmax)/nutrient mix
ture F12 (Gibco) with 10% fetal bovine serum (FBS: Invitrogen) and in
cubated at 37 °C at 5% CO2. Subsequently, cells were passaged and
diluted to obtain the seeding density of 104 cells/cm2. They were placed
on the ﬂat plate of 3DOM BG and 3DOM BG/Fe samples for 14 days for
the continual growth and adherence test. Non adherent cells that can
affect the culture condition were eliminated by replacing the media
every 3 days for a normal cellular growth. After the adherence test,
media was decanted. The cells were washed in phosphate buffered sa
line (PBS) and ﬁxed in 4% formalin. They were then washed in distilled
water and ﬁnally dehydrated for FESEM inspection.
3. Results
3.1. Bioactivity of 3DOM BG
According to FESEM images in Fig. 1, the 3DOM BG (sample 80S/
0Fe) was degraded and the HAp like feature was formed by the SBF
soaking. Fig. 1(b) indicates deterioration due to the prior release of
some soluble silica and Fig. 1(c) demonstrates the initial stage of the
crystalline HCA growth. Ultimately, the ﬂake like HCA crystals clearly
cover the surface of the sample within 21 days as shown in Fig. 1(d).
FESEM also reveals the distortion in the 3DOM structure by interaction
between template and precursors due to the addition of Na2O. The
phase separation occurs due to the increase in gel phase resulting in
the microspheres on the surface of 3DOM structure as exempliﬁed inFig. 2(a). However, the biocompatibility is not affected and the dissolu
ble efﬁcacy aswell as the HCA crystalline growth on the surface of these
microspheres is conﬁrmed in the FESEM images.
Fig. 3 compares elemental composition between before and after
soaking in SBF for 14, 21 and 28 days. The quantities in wt% of all ele
ments are averaged from over 10 different positions on the sample sur
face. The Ca and Na are initially decreased after 14 days of SBF soaking
but the SBF soaking for 21 28 days leads to large increases in Ca as
well as P. For 28 days of SBF soaking, the Ca/P molar ratio is approxi
mately 1.57. The Si is increased after the 14 days of SBF soaking and sub
sequently decreased until close to zero for 28 days soaking. This EDS
analysis conﬁrms the formation of the crystalline HCA phase.
In Fig. 4, the transmittance peaks of FTIR spectra verify the character
istics of bioactive glasses. At the top spectrum, the sample without
soaking in SBF exhibits the peaks at 471, 802, 1095 cm−1 and the shoul
der at 1095 1220 cm−1 corresponding to the vibration of Si O Si bond
and the peak at 567 cm−1 correlates to the P O vibrational peak. In
additions, the vibrational peak at 1630 and 3448 cm−1 assigned to
O H bonds indicates the water trapped inside the sample. After the
soaking in SBF, the aforementioned vibrational peaks are still observed.
The P O peak at 567 cm−1 split into doublet peak at 565 cm−1 and
Fig. 7. FESEM images of sample 70S/10Fe (a) before soaking in SBF and after soaking in SBF
magniﬁcation.
Fig. 6. XRD spectra of sample 80S/0Fe before and after soaking in SBF for 14 days.602 cm−1 and an additional P O peak can be found at 968 cm−1. In
additions, the vibrational peaks around 1380, 1414 and 1448 cm−1
can be assigned to the carbonate group [17 19].
In Fig. 5, the Raman scattering spectrum of 80S/0Fe sample does not
exhibit any peak before soaking in SBF since the laser beam in the mea
surement is only focused on the sample surface. After soaking in SBF for
28 days, theweak peaks at 430, 591 and 1070 cm−1 aswell as the sharp
and strong peak at 961 cm−1 distinctly conﬁrm the growth of HAp crys
talline phase. The peaks at 430 and 591 cm−1 are related to the O P O
bendingmode. The peaks at 961 and 1070 cm−1 correspond to the sym
metric stretching mode of P O bond of PO43− and the asymmetric
stretching mode of P O bond [20 21].
Likewise, the XRD patterns shown in Fig. 6 indicate the characteristics
of bioactive glasses. A broad reﬂection around 15 30° indicates with
amorphous nature of this glassy sample. Before soaking in SBF, additional
reﬂections at 31.7, 34.5 and 48.4° respectively corresponding to (330),
(331) and (541) planes are assigned to calcium phosphate silicate
(JCPDS 040 0393). After soaking in SBF for 14 days, the peak positions at
26.0, 32.0, 39.8, 46.9, 49.8 and 53.3° are assigned to (002), (211), (310),
(222), (213) and (004) reﬂections of HAp, respectively (JCPDS 09 0432).for (b) 7 days, (c) 14 days, (d) 21 days, (e) 28 days and (f) 28 days shown in a lower
3.2. Bioactivity of 3DOM BG/Fe
The FESEM images in Figs. 7 9 reveal the surface of 3DOM BG/Fe
samples during the bioactivity test. The feature changes after soaking
in SBF suggest a different mechanism compared to nonmagnetic 80S/
0Fe. A slight change in all 3DOM BG/Fe samples can be observed after
soaking in SBF for 7 days. The skeletal walls become thicker after
14 days of soaking in SBF. Obviously, the HAp like feature clearly
grows after soaking in SBF for 21 days and most surfaces are covered
within 28 days of SBF soaking.
Fig. 10(a) shows the formation microspheres on some outer surface
of 50S/30Fe sample similar to those in 80S/0Fe sample. After soaking in
SBF, the slightly dissolved silica HAp like features are revealed as in Fig.
10(b). The elemental compositions in the 3DOM BG/Fe before and after
the in vitro test are analyzed by EDS. The values averaged from over 10
positions on sample 70S/10Fe, 60S/20Fe and 50S/30Fe are respectively
compared in Fig. 11(a), (b) and (c). By soaking the samples in SBF, Ca
and Na are slightly changed after 14 days and then clearly increased
after 21 and 28 days. The Ca/P molar ratio of all samples is only around
0.8 after 28 days and Fe in these 3DOM BG/Fe samples is increased after
soaking in SBF.Fig. 8. FESEM images of sample 60S/20Fe (a) before soaking in SBF and after soaking in SBF
magniﬁcation.FTIR spectra for sample 70S/10Fe in Fig. 12(a) show vibrational
peaks related to the Si O Si bending at 465 and 1090 cm−1 and
stretching at 804 cm−1. The P O vibrational peak is observed at
565 cm−1. According to FTIR spectra of high purity iron oxide
nanopowders (N99.5%, US Research Nanomaterials, Inc.), the Fe O
vibrational peaks for Fe3O4 at 588 cm−1, γ Fe2O3 at 586 cm−1 and α
Fe2O3 at 568 cm−1 are close to the P O peak. Moreover, the Fe O
vibrational peaks of Fe3O4 at 1047 and 1094 cm−1 as well as γ Fe2O3
at 1063 cm−1 are comparable to the Si O Si peak. Hence the
Fe O peaks cannot clearly be identiﬁed. Unlike sample 80S/0Fe,
the splitting of P O vibrational peak cannot be observed in
sample 70S/10Fe after the SBF soaking. The vibrational peak
assigned to the carbonate group is observed at 1385 cm−1. In ad
ditions, the vibrational peak related to H2O is located at 1632 and
3450 cm−1.
In Fig. 12(b) and (c), samples 60S/20Fe and 50S/30Fe exhibit vibra
tional peaks of Si O Si, and P O similar to those of sample 70S/10Fe.
The Fe O peak can also be clearly observed at 698 cm−1. The vibrational
peak at around 1730 cm−1 corresponded to a carbonyl group and the
peaks assigned to the carbonate group at 1385, 1450 and 1493 cm−1
are explicitly found with the increase in Fe composition. After soakingfor (b) 7 days, (c) 14 days, (d) 21 days, (e) 28 days and (f) 28 days shown in a lower
Fig. 9. FESEM images of sample 50S/30Fe (a) before soaking in SBF and after soaking in SBF for (b) 7 days, (c) 14 days, (d) 21 days, (e) 28 days and (f) 28 days shown in a lower
magniﬁcation.in SBF, only peak assigned to carbonate at 1385 cm−1 remains while
other peaks correlated to carbonyl, carbonate and iron oxide gradually
disappear. The splitting of P O peak is not observed. Most vibrational
peaks of 3DOM BG/Fe samples tend to shift to lower wavenumbers
than those of 3DOM BG (sample 80S/0Fe). This trend also corresponds
to the increase in iron oxide concentration.Fig. 10. FESEM images showing microspheres on some surfaces of sample 50Before soaking in SBF, four Raman peaks can be observed in Fig.
13(a) for sample 70S/10Fe. The peak at 339 and 702 cm−1 can be
assigned to γ Fe2O3 [22]. The peak at 965 cm−1 is a characteristic of
the symmetric stretching of P O bond. The broad peak at 1380 cm−1
can also be attributed to the symmetric stretch of the P=O bond [23].
After soaking in SBF for 28 days, several Raman shifts are observed.S/30Fe (a) before soaking in SBF and (b) after soaking in SBF for 28 days.
Fig. 11. Comparison of EDS composition analysis of 3DOM-BG/Fe samples before and after
soaking in SBF for 14, 21 and 28 days; samples (a) 70S/10Fe, (b) 60S/20Fe and (c) 50S/
30Fe.
Fig. 12. FTIR spectra of 3DOM-BG/Fe samples before and after soaking in SBF for 6 h–
14 days; samples (a) 70S/10Fe, (b) 60S/20Fe and (c) 50S/30Fe.For iron oxide peaks, the peaks at 228, 293 and 427 cm−1 are attributed
to α Fe2O3 and the peaks at 337, 487, 572 and 671 cm−1 correspond to
γ Fe2O3 [22,24,25]. However, there is a peak shift in the symmetric
stretching of P O bond from 965 cm−1 to 971 cm−1.
In Fig. 13(b) and (c), the Raman spectra exhibit comparable peaks to
those of sample 70S/10Fe. For sample 60S/20Fe before SBF soaking, the
peaks at 473 and 691 cm−1 correspond to γ Fe2O3 and the peak at
973 cm−1 is attributed to the P O bond observed. After soaking in SBF
for 28 days, the peaks corresponding to γ Fe2O3 are found at 330, 487
and 719 cm−1. The peak attributed to the P O bond is shifted to
979 cm−1. For sample 50S/30Fe, the peaks at 334, 479 and 704 cm−1 at
tributed to γ Fe2O3 can be observed before SBF soaking. The peaks at
978 and 1380 cm−1 are respectively due to P O and P=O bonds.
After soaking for 28 days, all peaks are still present with slightlydifferent intensity. However, the position of P O peak is not shifted
for this sample.
The XRD is used to probe the formation of HAp crystalline phase on
sample surface. In Fig. 14, the XRD pattern of each 3DOM BG/Fe sample
has a broad reﬂection in the 15 30° regime indicating the amorphous
structure of the glass. Sample 70S/10Fe reveals the weakly additional
Fig. 14. XRD spectra of 3DOM-BG/Fe samples of (a) 70S/10Fe, (b) 60S/20Fe, and (c) 50S/
30Fe before and after soaking in SBF for 14 days.
Fig. 13. Raman spectra of 3DOM-BG/Fe samples before and after soaking in SBF for
28 days; samples (a) 70S/10Fe, (b) 60S/20Fe and (c) 50S/30Fe.reﬂection at 31.7° assigned to the (330) reﬂection of calcium phosphate
silicate (JCPDS 040 0393). Samples 60S/20Fe and 50S/30Fe exhibitweak
and broad characteristic diffraction peaks of γ Fe2O3 at 35.6, 57.2 and
62.7° respectively corresponding to the (311), (511), and (440) reﬂec
tions (JCPDS 04 0755). However, other peaks assigned to the HAp crys
talline phase are not observed after soaking in SBF for 14 days.
3.3. Stem cell attachment
From FESEM images in Fig. 15, the hADSCs are well attached and
spread on surface of each sample after the cell culture for 14 days.
These cells are over 100 μm in size and mostly triangular in shape.4. Discussion
4.1. Bioactivity of 3DOM BG
The bioactivity of 3DOM BG is clearly demonstrated in the in vitro
testing at the controlled temperature of 37 °C. When sample 80S/0Fe
is soaked in SBF, the ﬁrst reaction is the ionic exchange between Ca2+
and Na+ linked nonbridging oxygen (NBO) (Si O Ca and Si O Na)
with H+ from solution. The presence of Na+ in this sample facilitates
such exchange. This reaction results in the increase in pH due to the
increase in OH− in the solution. The bridging oxygen (BO) breaking of
Si O Si bonds is consequently induced by the increase in OH− and
leads to the release of some silica in form of Si(OH)4 and the formation
of Si OHgroups at the interface. The SiO2 rich layer then condenses and
repolymerizes on the surface depleted in Ca2+ and Na+. Subsequently,
the amorphous CaO P2O5 rich ﬁlm is formed on the top of the SiO2 rich
layer resulting from the Ca2+ and PO43−migration to the top. This ﬁlm is
incorporated by Ca2+ and PO43− from solution leading to the ﬁlm
growth. It follows that the crystalline HCA is formed by the incorpora
tion of OH− and CO32− from the solution. These phenomena involving
the ﬁrst 5 stages of the bone bonding reaction in the Hench mechanism
[2,6] are explicitly revealed by FESEM images. Conclusively, the Na2O
additive promotes the degradability and bioactivity of the 3DOM BG.
In additions, the enhanced reactive surface areas of the 3DOM structure
also support the dissolution and resorption abilities resulting in the con
version to the bone like layer [5,26,27].
Although the absolute values are not precisely measured by EDS (it
is known to be semi quantative), the relative amount of each element
can be accurately analyzed (as long as standards used) by averaging
values over ten different positions on the sample surface. The initial de
crease of Ca and Na after SBF soaking indicates the ionic exchange
Fig. 15. FESEM images of cells attachment on surface of samples (a) 80S/0Fe, (b) 70S/10Fe, (c) 60S/20Fe and (d) 50S/30Fe after culturing for up to 14 days.reaction after the soaking. The large increases in Ca as well as P corre
spond to CaO P2O5 rich ﬁlms formed at the top of surface and the
growth of crystalline HCA. The increase of Si after the 14 days of SBF
soaking may involve the formation of SiO2 rich layer. The subsequent
decrease implies the formation of CaO P2O5 rich ﬁlms on the surface.
The minimum Si in the case of 28 days of SBF soaking indicates the
fully covered surface by CaO P2O5 rich ﬁlms and/or HCA. After 28 days
of SBF soaking, the Ca/P molar ratio of samples is similar to the 1.0 2.0
range of the value present in human body [28,29]. The characteristic
bonds of glass are revealed with the Si O Si and P O vibrational
peaks in FTIR spectra. The presence of amorphous phosphate groups
conﬁrms the HAp formation after the in vitro SBF test. The vibrational
peaks assigned to carbonate group also indicate the formation of crys
tallized HCA [30,31]. In additions, the Raman shift and XRD spectra
clearly conﬁrm the bioactivity of 3DOM BG.
4.2. Bioactivity of 3DOM BG/Fe
FESEM images demonstrate the HAp formation is apparently re
duced with the increase in Fe concentration. The ﬁrst stage of Hench
mechanism involving the ion exchange may be disrupted. The Fe is in
corporated in 3DOM BG/Fe samples at the expense of Ca [32]. Therelease of Ca2+ from 3DOM BG/Fe surface which induces the silica dis
solution is decreased. However, the feature resembled HAp crystalline
phase is formed on the surface by the agglomeration of Ca and P from
the SBF. Although the microspheres disrupt some part of 3DOM struc
ture, they do not affect the bioactivity of 3DOM BG/Fe samples.
After the SBF soaking, the changes in all elements observed by EDS
can be explained according to the Hench mechanism. Initially, the de
creases of Ca and Na signify the ﬁrst stage of ion exchange. The slight
changes of Ca and Na correspond to feature changes previously shown
by the FESEM images. Subsequent increases in Si as well as Ca and P
are due to the formation of SiO2 rich layer and CaO P2O5 rich ﬁlm, re
spectively. However, the increases in Ca and P are smaller than that of
the nonmagnetic 3DOM BG indicating that the presence of Fe disrupts
the mechanism of HAp growth on these bioactive glasses. The Ca/P
molar ratios are not in range of the value in human body. The presence
of Fe reduces the ionic exchange, and hence, a less amount of silica is
dissolved. The increases in Ca and P after soaking in SBF for 21 and
28 days are due to the sedimentation or agglomeration of Ca and P on
the surface of samples during the process of HAp formation. However,
the rate is slow since the Ca/P ratio does not reach the value in human
body after 28 days of SBF soaking. So, all 3DOM BG/Fe samples are de
cidedly less bioactive than the nonmagnetic 3DOM BG. The increase of
Fe after soaking in SBF indicates the minimal release from the surface.
Thisﬁnding suggests that iron oxideswill be preservedwithin the struc
ture when these magnetic bioactive glasses are implemented in hyper
thermia treatment.
The Fe O bonds probably overlap the FTIR vibrational peaks with
characteristic peaks of bioactive glass [11,33,34]. After soaking in SBF,
the changes in structural bonding occurred and the effect of iron oxide
concentration result in the lower wavenumbers of most vibrational
peaks. In additions, Raman spectra clearly show the bioactivity of
3DOM BG/Fe. The peak shift corresponding to the symmetric stretching
of P O bond is clearly correlated to the increase in Fe concentration.
These peak shifts indicate the increase in average length of P O bonds
[23]. The peak shift of P O bond, also inﬂuenced by the SBF soaking, is
decreased by the increase in Fe composition. For the 50S/30Fe sample
with the highest concentration of iron oxide, the peak shift due to the
SBF soaking does not occur like in other cases. Moreover, the Raman
shift is found only for the peak related to γ Fe2O3. The γ Fe2O3
nanocrystals is increasingly formed with increasing amounts of Fe.
Although the in vitro bioactivity of 3DOM BG/Fe samples is evident,
the HAp phase is not conﬁrmed. The presence of Fe in bioactive glass
matrix apparently disrupts the formation of HAp. Nevertheless, the
Ca P layers are grown on 3DOM BG/Fe surfaces as shown in FESEM im
ages and XRD patterns.
4.3. Stem cell attachment
The attachment and well spread of cells on all sample surfaces indi
cating the good biocompatibility. While the degradability and the HAp
crystalline phase formation are important to initiate the bone tissue re
generation, the low biodegradability of 3DOM BG/Fe does not disrupt
the cell adhesion. The presence of Fe composition reveals no cytotoxic
ity. The osteoblast is an indication of the capacity of the growth and pro
liferation on the 3DOM BG aswell as 3DOM BG/Fe samples synthesized
in this research.
5. Conclusions
In this study, the initial step of HAp growth according to the Hench
mechanism leading to the bone bonding on 3DOM BG is clearly shown.
The XRD, FTIR and Raman spectra conﬁrm the structure of chemical
bonds and functional groups of bioactive glasses corresponding to the
HAp formation during the SBF soaking. The in vitro test by soaking
3DOM BG/Fe samples in SBF indicates different bioactivity from that of
the 3DOM BG. The HAp like layer has a lower growth rate in the case
of higher Fe concentration. The EDS indicates that the Ca/P ratio is not
close to the value found in human bone even after soaking in SBF for
28 days. However, the well adhesion and spread of hADSCs on the ﬂat
plate sample after 14 days of the stem cell culture also conﬁrm the bio
compatibility of both 3DOM BG and 3DOM BG/Fe. The inclusion of iron
oxide does not lead to cytotoxicity and the osteoblast can be grown
and proliferated. The presence of iron oxide with superparamagnetic be
havior is useful for hyperthermia therapy owing to the induced heat
under the alternating magnetic ﬁeld. The magnetization is increased
with the increase in Fe(NO3)3·9H2O from 10 to 30 mol%. The potential
applications of these multifunctional bioactive glasses us to replace, re
pair and regenerate bone defects especially in the bone cancer therapy.
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